Careers
Contact
Pharmacovigilance
Whistleblowing
Foundation
Holdings
Global
Global
it
us
Dompé Italy
Dompé US
Dompé China
Foundation
Exscalate
Who We Are
About Us
Our Heritage
Management Team
Responsibility
Environment, Quality and Safety
Ethics and Compliance
Where We Are
Science
Nerve Growth Factor
NETosis
Reparixin
Ladarixin
Pipeline
Publications
Exscalate
Therapeutics
Ophthalmics
Neurotrophic Keratitis
Primary & Speciality Care
Pain and Anti-inflammatory
Prevention
Cough and Cold
Eye, Skin & Oral Care
Cardiovascular
Gastro
Managed Access Programs
Manufacturing
Production Plant
Biotech
Pharma
People & Culture
Media
Press Releases
Dompé in the News
Stories
Media Library
Search
Search
Inhibition of interleukin-8 (CXCL8/IL-8) Responses by Repertaxin, a New Inhibitor of the Chemokine Receptors CXCR1 and CXCR2
31/01/2005
Authors:
F Casilli et al.
Published in:
Biochemical pharmacology
Preclinical Programs
Find out more